Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 6, 2006, Pages 717-724

  Ragab, S M ^a   Lund, V J ^b   Saleh, H A ^c   Scadding, G ^d,e  

^a TANTA UNIVERSITY HOSPITAL   (Egypt)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^e RNTNE Hospital   (United Kingdom)

Author keywords

Chronic rhinosinusitis; Computerized tomographic scan; Endoscopic sinus surgery; Nasal nitric oxide; Nasal polyposis; Saccharin clearance time; Symptom scores

Indexed keywords

DEXAMETHASONE ISONICOTINATE; ERYTHROMYCIN; FLUTICASONE PROPIONATE; NITRIC OXIDE; PREDNISOLONE; SACCHARIN; TRAMAZOLINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DRUG TREATMENT FAILURE; ENDOSCOPIC SURGERY; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL ASSESSMENT; NON INVASIVE MEASUREMENT; NOSE POLYP; NOSE SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; SCORING SYSTEM; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; CHRONIC DISEASE; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMIDAZOLES; MALE; NASAL CAVITY; NASAL POLYPS; NEOMYCIN; NITRIC OXIDE; RHINITIS; SINUSITIS; TREATMENT FAILURE;

EID: 33744466304     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01044.x     Document Type: Article

References (43)

1. Lundberg JO Rinder J Weitzberg E Lundberg JM Alving K. Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses. Acta Physiol Scand 1994 152 : 431 432.
2. Lundberg JO Farkas-Szallasi T Weitzberg E Rinder J Lidholm J Anggaard A et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995 1 : 370 373.
3. Gaston B Reilly J Drazen JM Fackler J Ramdev P Arnelle D et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A 1993 90 : 10957 10961.
4. Liu SF Crawley DE Barnes PJ Evans TW. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis 1991 143 : 32 37.
5. Martinez C Cases E Vila JM Aldasoro M Medina P Marco V et al. Influence of endothelial nitric oxide on neurogenic contraction of human pulmonary arteries. Eur Respir J 1995 8 : 1328 1332.
6. Bai TR Bramley AM. Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi. Am J Physiol 1993 264 5 Pt 1 L425 L430.
7. Belvisi MG Stretton CD Miura M Verleden GM Tadjkarimi S Yacoub MH et al. Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. J Appl Physiol 1992 73 : 2505 2510.
8. Wei XQ Charles IG Smith A Ure J Feng GJ Huang FP et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995 375 : 408 411.
9. Laubach VE Shesely EG Smithies O Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 1995 92 : 10688 10692.
10. Xie K Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 1998 17 : 55 75.
11. Lala PK. Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy. Cancer Metastasis Rev 1998 17 : 1 6.
12. Jain B Rubinstein I Robbins RA Leise KL Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993 191 : 83 88.
13. Runer T Cervin A Lindberg S Uddman R. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg 1998 119 : 278 287.
14. Runer T Lindberg S. Effects of nitric oxide on blood flow and mucociliary activity in the human nose. Ann Otol Rhinol Laryngol 1998 107 : 40 46.
15. Gerlach H Rossaint R Pappert D Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993 23 : 499 502.
16. Puybasset L Rouby JJ Mourgeon E Stewart TE Cluzel P Arthaud M et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994 20 : 319 327.
17. Beckman JS Beckman TW Chen J Marshall PA Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990 87 : 1620 1624.
18. Rubbo H Radi R Trujillo M Telleri R Kalyanaraman B Barnes S et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994 269: 26066 26075.
19. Baraldi E Azzolin NM Biban P Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997 155: 1680 1683.
20. Colantonio D Brouillette L Parikh A Scadding GK. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy 2002 32 : 698 701.
21. Arnal JF Flores P Rami J Murris-Espin M Bremont F Pasto IA et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999 13 : 307 312.
22. Lundberg JO Weitzberg E Nordvall SL Kuylenstierna R Lundberg JM Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J 1994 7 : 1501 1504.
23. Balfour-Lynn IM Laverty A Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996 75 : 319 322.
24. Dotsch J Demirakca S Terbrack HG Huls G Rascher W Kuhl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996 9 : 2537 2540.
25. Kharitonov SA Rajakulasingam K O'Connor B Durham SR Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997 99 1 Pt 1 58 64.
26. Martin U Bryden K Devoy M Howarth P. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996 97 : 768 772.
27. Arnal JF Didier A Rami J M'Rini C Charlet JP Serrano E et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997 27 : 358 362.
28. Kharitonov SA Yates D Robbins RA Logan-Sinclair R Shinebourne EA Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994 343 : 133 135.
29. Persson MG Zetterstrom O Agrenius V Ihre E Gustafsson LE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994 343 : 146 147.
30. Massaro AF Gaston B Kita D Fanta C Stamler JS Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995 152 : 800 803.
31. Saleh D Ernst P Lim S Barnes PJ Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998 12 : 929 937.
32. Lindberg S Cervin A Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997 117 : 113 117.
33. Warke TJ Mairs V Fitch PS McGovern V Ennis M Shields MD. Exhaled nitric oxide in relation to the clinical features of childhood asthma. J Asthma 2004 41 : 751 757.
34. Berkman N Avital A Breuer R Bardach E Springer C Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 2005 60 : 383 388.
35. Warke TJ Fitch PS Brown V Taylor R Lyons JD Ennis M et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002 57 : 383 387.
36. Ragab SM Lund VJ Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004 114 : 923 930.
37. Lund VJ Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl 1995 167 : 17 21.
38. Lund VJ Mackay IS. Staging in rhinosinusitus. Rhinology 1993 31 : 183 184.
39. Mackay IS Lund VJ. Imaging and staging. In : Mygind N Lildholdt T, editors. Nasal Polyposis. An Inflammatory Disease and Its Treatment. Copenhagen : Munksgaard, 1997 : 137 144.
40. Stammberger H. Surgical technique. In : Stammberger H, editor. Functional Endoscopic Sinus Surgery The Messerklinger Technique. Philadelphia, PA : B.C. Decker, 1991 : 283 320.
41. Kim JW Min YG Rhee CS Lee CH Koh YY Rhyoo C et al. Regulation of mucociliary motility by nitric oxide and expression of nitric oxide synthase in the human sinus epithelial cells. Laryngoscope 2001 111 : 246 250.
42. Lindberg S Cervin A Runer T. Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta Otolaryngol 1997 117 : 728 734.
43. Baraldi E Azzolin NM Carra S Dario C Marchesini L Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir Med 1998 92 : 558 561.